Oct 1, 2026 07:34AM
Oct 1, 2026 07:30AM
Apr 23, 2026 04:15PM
Apr 23, 2026 04:15PM
Apr 21, 2026 09:30PM
Apr 21, 2026 09:30PM
Apr 20, 2026 04:01PM Nektar Therapeutics launches $250 million public offering
Apr 20, 2026 04:01PM
Apr 20, 2026 07:43AM
Apr 20, 2026 07:30AM
Feb 13, 2026 04:15PM
Feb 13, 2026 04:15PM
Feb 11, 2026 10:24PM
Feb 11, 2026 10:23PM Nektar Therapeutics Announces Pricing of Upsized $400 Million Public Offering
Feb 10, 2026 04:05PM
Feb 10, 2026 04:05PM
Dec 16, 2025 07:30AM
Dec 16, 2025 07:30AM
Nov 12, 2025 04:08PM
Jul 29, 2025 09:01AM
Jul 29, 2025 09:00AM Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Severe-to-Very Severe Alopecia Areata
Jul 2, 2025 04:15PM
Jul 1, 2025 07:18AM
Jul 1, 2025 07:17AM
Jun 30, 2025 04:03PM
Jun 30, 2025 04:02PM
Mar 28, 2025 04:23PM
Feb 26, 2025 07:01AM Nektar Therapeutics (NKTR) Announces Completion of Target Enrollment in REZOLVE-AA Phase 2b Clinical Trial of Rezpegaldesleukin
Feb 26, 2025 07:00AM
May 28, 2024 04:52PM
Mar 5, 2024 09:00AM
Nov 8, 2017 09:22AM
Nov 7, 2017 06:08PM
Mar 2, 2010 05:32PM

73,479 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All